U.S. Transportation Stock News

Peoples Bancorp recently reported three consecutive quarters of improving earnings per share, supported by strong loan portfolio growth and tighter cost control, and previously announced it would release its first quarter 2026 results and hold an earnings call on April 21, 2026. This pattern of loan-driven earnings improvement is giving the bank greater financial flexibility and could influence how investors view its longer-term prospects and risk profile. Next, we’ll examine how this run of...

Atour Lifestyle Holdings (NasdaqGS:ATAT) has been in focus after its latest quarterly report topped earnings expectations, completed the “2,000 Premier Hotels” initiative, and introduced a new three year “Brand Led Excellence” plan. See our latest analysis for Atour Lifestyle Holdings. Atour’s latest earnings beat and new “Brand Led Excellence” plan have arrived after a mixed share price stretch, with a 4.47% 7 day share price return but a 9.08% 90 day decline. At the same time, the 1 year...

In March 2026, Expro Group Holdings’ board approved a plan to move its corporate domicile from the Netherlands to the Cayman Islands, while the company also agreed to provide advanced GeoFlow™ surface well testing and related services to support VERCANA GmbH and Vulcan Energy’s Lionheart geothermal and lithium project in Europe. The planned redomicile highlights management’s focus on governance flexibility and corporate simplification, while the Lionheart engagement underscores Expro’s role...

Saia (SAIA) moved higher in response to broader market relief after reports that President Trump was considering de-escalation of the military conflict in Iran, which eased worries about energy costs and industrial activity. See our latest analysis for Saia. At a latest share price of $354.28, Saia has a 7 day share price return of 5.97% and a 1 year total shareholder return of 9.90%, suggesting recent momentum has picked up after a more measured longer term outcome. If this kind of move has...

CMS coding update puts Inspire Medical Systems (INSP) in focus Recent confirmation that new CMS hypoglossal nerve stimulation C codes will share the same APC 5465 as CPT 64582, keeping hospital facility fees broadly unchanged, has put Inspire Medical Systems (INSP) back on investor watchlists. See our latest analysis for Inspire Medical Systems. The latest CMS coding clarity arrives as the share price trades at US$54.99, with a 1 day share price return of 2.52% and a 7 day share price return...

Analyst optimism and recent stock move Recent upward revisions to earnings estimates and revenue forecasts for Everpure (PSTG), together with a consensus Outperform rating, have coincided with the stock outperforming the broader market in recent trading sessions. See our latest analysis for Everpure. At a share price of US$62.48, Everpure has recently posted a 2.31% 1 day share price return and a 5.93% 7 day share price return. However, its 90 day share price return shows a decline of 10.31%,...

Legend Biotech recently reported record quarterly sales and profitability milestones for its CARVYKTI multiple myeloma therapy, alongside expanded global access and the past removal of FDA REMS restrictions that had limited how patients were monitored and allowed to drive. These updates highlight how CARVYKTI has become one of the most widely used CAR-T treatments, supported by long-term survival data, growing manufacturing capacity and broader international launches that together could...

DXP Enterprises (DXPE) is back on investors' radar after its share price moved higher, accompanied by a recent wave of upward earnings estimate revisions and consistently strong buy ratings from all covering analysts. See our latest analysis for DXP Enterprises. The recent uptick in earnings expectations appears to be feeding into strong momentum, with the share price at $143.34, a 90 day share price return of 36.85% and a 1 year total shareholder return of 95.15% highlighting sustained...

In early April 2026, Celldex Therapeutics completed a follow-on public equity offering of 10,345,000 common shares at US$29.00 each, raising about US$300.01 million to support barzolvolimab launch preparation, pipeline development and general corporate needs. This financing closely followed detailed Phase 2 data showing barzolvolimab’s potential to meaningfully improve quality of life in difficult-to-treat chronic urticaria, underscoring Celldex’s focus on translating clinical momentum into...

Recently, Cheniere Energy Partners highlighted that its long-term LNG capacity is largely contracted and that it has expanded supply agreements with counterparties in Thailand and Taiwan, supporting more predictable future volumes. An interesting angle is how these extended contracts, combined with management’s planned capacity expansions, could make the partnership’s cash flows more stable and less sensitive to short-term price swings. With the company’s shares posting modest gains over the...

Duke Energy (DUK) is back in focus after securing approval for a new natural gas plant in South Carolina, closing the sale of its Tennessee gas business, and reporting earnings that topped expectations. See our latest analysis for Duke Energy. The recent approval for new natural gas capacity in South Carolina and the completed sale of the Tennessee gas business arrive while Duke Energy’s 90 day share price return of 13.19% and 1 year total shareholder return of 15.11% suggest momentum has...

Aveanna’s latest earnings move and analyst reaction Aveanna Healthcare Holdings (AVAH) is back on investors’ radar after its fourth quarter update, where management reported 20.2% annual revenue growth and a 74.8% increase in Adjusted EBITDA, followed by Barclays revisiting its view on the stock. See our latest analysis for Aveanna Healthcare Holdings. At a latest share price of $6.38, Aveanna’s short term share price performance has been weak, with a 30 day share price return of an 11.8%...

Despite the fact that Pulmonx Corporation (NASDAQ:LUNG) stock rose 14% last week, insiders who sold US$371k worth of...

On March 23, 2026, Sonoco Products Company entered into a new unsecured delayed draw term loan facility of up to US$300 million, providing flexible two-year funding with variable interest tied to Term SOFR or a base rate and customary financial covenants. This additional credit capacity, with no required amortization and the ability to prepay without penalty, gives Sonoco room to manage upcoming funding needs while maintaining balance sheet discipline through minimum net worth and interest...

AAR Corp. recently reported fiscal third-quarter 2026 results showing higher sales and earnings versus a year earlier, confirmed strong fourth-quarter guidance, and completed a share repurchase of 2,429,700 shares for US$107.54 million, while also securing long-term U.S. Air Force pallet contracts worth up to about US$450 million. These earnings, guidance and contract wins, alongside new long-duration logistics work for Navy and Marine Corps C-40A aircraft, underline how government programs...

CNH Industrial (NYSE:CNH) recently extended its €3.25b committed revolving credit facility with Citibank Europe to April 18, 2031. This move supports long term liquidity and reduces refinancing pressure for shareholders. See our latest analysis for CNH Industrial. Recent trading has been choppy, with a 1 day share price return of 3.36% decline and a 30 day share price return of 4.48% decline. However, the 90 day share price return of 10.36% and year to date share price return of 13.90% point...

Shares of KeyCorp (KEY) have been in focus after easing tensions with Iran reduced perceived geopolitical risk and supported a rally in regional bank stocks as investors reassessed economic uncertainty and potential credit conditions. See our latest analysis for KeyCorp. At a share price of $20.47, KeyCorp has seen a 5.24% 7-day share price return and a softer 90-day return of a 4.21% decline, while its 1-year total shareholder return of 58.92% and 3-year total shareholder return of 102.76%...

In recent months, International Paper has faced weaker demand, higher costs, and heavy restructuring charges, alongside analyst concerns over its softer results and execution risks. Together with falling free cash flow margins and declining returns on invested capital, these pressures are prompting investors to question the company’s longer-term profit potential and growth options. We’ll now examine how this combination of cost headwinds and muted packaging demand could reshape International...

Walker & Dunlop (WD) recently arranged a joint venture and financing package for a US$132 million multifamily redevelopment at Richmond’s former Greyhound bus station, giving investors a fresh data point on its capital markets activity. See our latest analysis for Walker & Dunlop. Despite arranging high profile redevelopment financings, Walker & Dunlop’s recent trading tells a different story. The company has a 7 day share price return of 3.23%, but a year to date share price return decline...

Kilroy Realty (KRC) is back in focus after mixed Q4 2025 results, with strong leasing activity but earnings well below expectations, alongside plans to shift capital into life science assets via acquisitions and property sales. See our latest analysis for Kilroy Realty. The mixed Q4 update, planned shift toward life science assets and recent dividend declaration have been met with weak momentum in the share price, with a 90 day share price return of a 25.8% decline even as the 1 year total...

Without a specific news announcement to anchor today, Vistra (VST) is drawing attention as investors weigh its recent share performance, current valuation signals, and the scale of its US$51.2b market footprint. See our latest analysis for Vistra. At a share price of US$151.18, Vistra has seen short term share price pressure, with a 7 day share price return of 2.77% and a 90 day share price return decline of 7.21%. However, its 1 year total shareholder return of 54.94% points to strong longer...

What recent returns say about Five Below Without a specific news headline driving attention today, Five Below (FIVE) is on some investors radar because of its recent share performance and the company’s position in the U.S. value retail space. The stock shows a 0.2% return over the past day, 6.2% over the past week, about 9.3% over the past month, and roughly 19.7% over the past 3 months, with year to date return at 21.7%. See our latest analysis for Five Below. At a share price of $235.39,...

The promotion of Kristin Wolf to Chief Strategy & Growth Officer positions Ulta Beauty (ULTA) at the center of an expanded push into international markets, wellness partnerships, AI, and digital commerce channels like TikTok Shop. See our latest analysis for Ulta Beauty. That appointment comes as Ulta Beauty’s 1 year total shareholder return of 49.54% contrasts with a 30 day share price return of 16.86% and a year to date share price return of 13.33% decline. This hints that recent volatility...

In recent months, Mirum Pharmaceuticals reported very large year-over-year net product revenue growth, reached GAAP profitability, raised full-year revenue guidance to about US$500 million, and secured multiple new approvals and trial milestones for its rare disease portfolio, including LIVMARLI and CTEXLI. This combination of improving financial performance and advancing late-stage studies, such as the EXPAND and VISTAS trials, is materially reshaping expectations for Mirum’s long-term rare...